{"DataElement":{"publicId":"3028697","version":"1","preferredName":"Tertiary 5 Gleason Score Prostate Cancer Evidence Cell Characteristic Percentage Value","preferredDefinition":"Percentage value to represent the amount of Tertiary Gleason 5 score present in a prostate cancer specimen.","longName":"TERT5_GLEA_PCT_VAL","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3028681","version":"1","preferredName":"Tertiary Integer::5 Gleason Score for Prostate Cancer Evidence","preferredDefinition":"Occurring third in place, order, degree, value, or rank._A number with no fractional part.::5_The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable._Knowledge on which to base belief.","longName":"TERT_GLEA_SC_EVID","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3028679","version":"1","preferredName":"Tertiary Integer::5 Gleason Score for Prostate Cancer","preferredDefinition":"Occurring third in place, order, degree, value, or rank.:A number with no fractional part.::5:A system of grading prostate cancer cells to determine the best treatment and to predict how well a person is likely to do. A low Gleason score means the cancer cells are very similar to normal prostate cells; a high Gleason score means the cancer cells are very different from normal. ","longName":"C71903:C45255::5:C28084","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tertiary","conceptCode":"C71903","definition":"Occurring third in place, order, degree, value, or rank.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gleason Score for Prostate Cancer","conceptCode":"C28084","definition":"The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"825F3F1F-3534-D22E-E040-BB89AD4374D6","latestVersionIndicator":"Yes","beginDate":"2010-03-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-22","modifiedBy":"ONEDATA","dateModified":"2010-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2503732","version":"1","preferredName":"Evidence","preferredDefinition":"Knowledge on which to base belief.","longName":"C43583","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Evidence","conceptCode":"C43583","definition":"Knowledge on which to base belief.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A80E2BF-CED8-2916-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-08-08","modifiedBy":"ONEDATA","dateModified":"2006-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"825F3F1F-3542-D22E-E040-BB89AD4374D6","latestVersionIndicator":"Yes","beginDate":"2010-03-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-22","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3028685","version":"1","preferredName":"Cell Characteristic Percentage Value","preferredDefinition":"values for the percentage for measurement of a trait of a specimen of tumor or other tissue._The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid._The distinguishing qualities or prominent aspect of a person, object, action, process, or substance._Percentage; a fraction or ratio with 100 understood as the denominator.","longName":"CELL_CHAR_PCT_VAL","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2178079","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"EDRN","contextVersion":"1","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"CC049DE1-E986-5FB4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3028684","version":"1","preferredName":"Cell Characteristic Percentage Value","preferredDefinition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.:Characteristics; distinguishing qualities of a person, object, or substance.:Percentage; a fraction or ratio with 100 understood as the denominator.:Value; a numerical quantity measured or assigned or computed.","longName":"C12508:C25447:C25613:CL052797","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Characteristic","conceptCode":"C25447","definition":"The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"CL052797","definition":"Value; a numerical quantity measured or assigned or computed.","evsSource":"NCI_META_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"825FF8E4-2232-6783-E040-BB89AD43233B","latestVersionIndicator":"Yes","beginDate":"2010-03-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-22","modifiedBy":"ONEDATA","dateModified":"2010-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"825FF8E4-2243-6783-E040-BB89AD43233B","latestVersionIndicator":"Yes","beginDate":"2010-03-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-22","modifiedBy":"ONEDATA","dateModified":"2010-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811715","version":"1","longName":"Duke University","context":"NCIP"},{"publicId":"2812724","version":"1","longName":"Duke U New CDEs","context":"NCIP"}]},{"publicId":"3886752","version":"1","longName":"For Review","context":"DCI","ClassificationSchemeItems":[{"publicId":"3891931","version":"1","longName":"For Review","context":"DCI"}]}],"AlternateNames":[{"name":"DCI","type":"USED_BY","context":"DCI"}],"ReferenceDocuments":[{"name":"If yes, %","type":"Preferred Question Text","description":"If yes, %","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"826348D1-5671-45E0-E040-BB89AD4367C8","latestVersionIndicator":"Yes","beginDate":"2010-03-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-22","modifiedBy":"ZHANGWE","dateModified":"2013-09-16","changeDescription":"Curated to support Duke University Prostate cancer trials.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}